NCT06979544 - A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

May 31, 2026

Conditions

Depression, PostpartumDepression, Post-PartumPostpartum Depression (PPD)Post-Natal DepressionPeripartum DepressionPostnatal Depression

Interventions

DRUG

LPCN 1154A

Oral LPCN 1154A tablets for 48 hours

DRUG

Placebo

Oral Placebo Tablets for 48 hours

Trial Locations (18)

19063

RECRUITING

Suburban Research Associates, Media

28112

RECRUITING

Monroe Biomedical Research, Monroe

30030

RECRUITING

CenExel Research Center, Decatur

30338

RECRUITING

Atlanta Behavioral Research, Atlanta

31405

RECRUITING

CenExel Research Center, Savannah

33014

RECRUITING

Meridian International Research, Miami Gardens

33145

RECRUITING

MedOne Clinical Research, LLC, Miami

33155

RECRUITING

D&H National Research Centers, Miami

67226

RECRUITING

Cypress Medical Research Center, LLC, Kansas City

70115

RECRUITING

Best Clinical Trials, New Orleans

77082

RECRUITING

New Dawn Wellness and Medical Center, Houston

77573

RECRUITING

Maximos OB/GYN, League City

77702

NOT_YET_RECRUITING

Gadolin Research, Beaumont

83404

RECRUITING

Clinical Research Prime, Idaho Falls

84604

RECRUITING

Populace Research, Provo

89121

RECRUITING

Oasis Clinical Research, Las Vegas

91304

RECRUITING

Alliance Research Institute, Canoga Park

92805

RECRUITING

Advanced Research Center, Anahiem